Aligos Therapeutics to Announce 1st Quarter 2026 Financial Results on May 7, 2026 Life Science Investing
Senseonics Announces Commencement of $80 Million Public Offering of Common Stock and Pre-Funded Warrants Life Science Investing
Stoke Therapeutics to Host Webcast and Conference Call to Discuss First Quarter 2026 Business and Financial Updates Life Science Investing
AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec Pharmaceutical Investing
Axsome Therapeutics Announces FDA Approval of AUVELITY® for the Treatment of Agitation Associated with Dementia due to Alzheimer's Disease Life Science Investing
BioRestorative Therapies to Present New Data at ISCT 2026 Highlighting Its Ongoing Phase 2 Clinical Trial in Chronic Lumbar Disease and Its BioCosmeceutical Platform Life Science Investing
FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy Medical Device Investing
